You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

List of Excipients in API dexamethasone intensol

✉ Email this page to a colleague

« Back to Dashboard

Excipients in ANDA-approved (generic) drugs containing dexamethasone intensol

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC	Excipient
Carilion Materials Management	dexamethasone intensol	68151-5026	ALCOHOL
Carilion Materials Management	dexamethasone intensol	68151-5026	BENZOIC ACID
Carilion Materials Management	dexamethasone intensol	68151-5026	CITRIC ACID MONOHYDRATE
Carilion Materials Management	dexamethasone intensol	68151-5026	EDETATE DISODIUM
Carilion Materials Management	dexamethasone intensol	68151-5026	PROPYLENE GLYCOL
Carilion Materials Management	dexamethasone intensol	68151-5026	WATER
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for dexamethasone intensol

Excipient focus: ALCOHOL

dexamethasone intensol drug variants containing ALCOHOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Carilion Materials Management	dexamethasone intensol	68151-5026
>Company	>Ingredient	>NDC

dexamethasone intensol drug variants not containing ALCOHOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: BENZOIC ACID

dexamethasone intensol drug variants containing BENZOIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Carilion Materials Management	dexamethasone intensol	68151-5026
>Company	>Ingredient	>NDC

dexamethasone intensol drug variants not containing BENZOIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CITRIC ACID MONOHYDRATE

dexamethasone intensol drug variants containing CITRIC ACID MONOHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Carilion Materials Management	dexamethasone intensol	68151-5026
>Company	>Ingredient	>NDC

dexamethasone intensol drug variants not containing CITRIC ACID MONOHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: EDETATE DISODIUM

dexamethasone intensol drug variants containing EDETATE DISODIUM

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Carilion Materials Management	dexamethasone intensol	68151-5026
>Company	>Ingredient	>NDC

dexamethasone intensol drug variants not containing EDETATE DISODIUM

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: PROPYLENE GLYCOL

dexamethasone intensol drug variants containing PROPYLENE GLYCOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Carilion Materials Management	dexamethasone intensol	68151-5026
>Company	>Ingredient	>NDC

dexamethasone intensol drug variants not containing PROPYLENE GLYCOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

dexamethasone intensol drug variants containing WATER

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Carilion Materials Management	dexamethasone intensol	68151-5026
>Company	>Ingredient	>NDC

dexamethasone intensol drug variants not containing WATER

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.